This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Carthew, P. Articles by Verschoyle, R.D. Search for Related Content PubMed PubMed Citation Articles by Carthew, P. Articles by Verschoyle, R.D. Social Bookmarking                         What's this?

A comparison of the acute pathology induced by 3-phenylamino-1,2-propanediol (PAP) and its mono-oleoyl ester in rodents with the toxic oil syndrome in man

Medical Research Council Toxicology Unit, Hodgkin Building, University of Leicester, Box 138, Lancaster Road, Leicester, LE1 9HN, UK

R.E. Edwards

Medical Research Council Toxicology Unit, Hodgkin Building, University of Leicester, Box 138, Lancaster Road, Leicester, LE1 9HN, UK

B.M. Dorman

Medical Research Council Toxicology Unit, Hodgkin Building, University of Leicester, Box 138, Lancaster Road, Leicester, LE1 9HN, UK

R.D. Verschoyle

Medical Research Council Toxicology Unit, Hodgkin Building, University of Leicester, Box 138, Lancaster Road, Leicester, LE1 9HN, UK

Phenylamino-1,2 propanediol (PAP) and its mono-oleoyl ester have been identified in samples of the cooking oil thought to be responsible for the Toxic Oil Syndrome (TOS) which occurred in Spain in 1981. The acute toxicity of PAP and its mono-oleoyl ester have been examined in rats and mice, after daily administration for periods of up to 14 days to determine whether these compounds could produce any of the pathologies of TOS. Even at the highest dose, the 1-mono-oleoyl ester of 3-phenylamino-1,2 propanediol did not cause any toxicity in rats or mice when given intraperitoneally. 3-Phenylamino-1,2 propane diol, however, was toxic when administered to rats by this route. After 6-10 consecutive daily doses of PAP, at the highest dose administered (350 mg kg^-1), all of the rats became unwell. Postmortem examination showed that the major pathology present was massive pulmonary throm boembolism. Further investigations of the toxicity of PAP after intravenous administration showed that it was not directly vasotoxic. The pulmonary thromboembolism seen with intraperitoneally administered PAP was due to the toxic effect of PAP on the mesenteric tissue and blood ves sels, causing thrombosis which subsequently embolised the blood vessels in the lung. Intra-gastric administration of PAP caused no toxicity in rats. Comparatively, the pathology seen after intraperitoneal administration of PAP was not thought to be representative of the pathology of the toxic oil syndrome in man.

Key Words: rodent toxicity • 3-phenylamino-1,2 propanedi ol • toxic oil syndrome • pulmonary toxicity • peritoneal toxi city

Human & Experimental Toxicology, Vol. 14, No. 2, 217-220 (1995)
DOI: 10.1177/096032719501400211


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. D. Koller, B. V. Stang, M. Posada de la Paz, and M. V. Ruiz Mendez Pathology of "Toxic Oils" and Selected Metals in the MRL/lpr Mouse Toxicol Pathol, October 1, 2001; 29(6): 630 - 638. [Abstract] [PDF]